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Introduction
Myeloid sarcoma (MS) is a rare extramedullary neoplasm 
composed of immature or mature granulocytes or mono-
cytes. In the literature, it is known by a variety of names 
including granulocytic sarcoma, monocytic sarcoma, myelo-
blastoma and chloroma. In 2%–8% of cases MS occurs 
before, during or after the onset of acute myeloid leukemia 
(AML) and, more rarely, in patients with myeloproliferative 
disorder. It is extremely rare its presentation without any 
prior history of myeloid neoplasm.1–3
It has been reported an increase in MS following allo-
genic stem-cell transplantation and some authors have sug-
gested that it may represent a reduced graft-versus-leukemia 
effect at extramedullary sites.4
MS can involve any anatomic site; however, lymph nodes, 
periostium, paranasal sinuses, soft tissue and skin are most 
commonly affected. The involvement of salivary glands is very 
rare and there are just a few cases reported in the literature.2,5,6
Case report
In January 2015, a 65-year-old woman presented with right 
submandibular slowly enlarging mass. Patient’s past history 
included a myelodysplastic syndrome diagnosed in 2010. In 
2011, after induction and consolidation chemotherapy, the 
patient had undergone allogenic hematopoietic stem-cell 
transplantation with a smooth, event-free course until July 
2014. From that time on she had started with periodic painful 
swelling of the right submandibular area without strict cor-
relation with eating. At that time patient underwent ultra-
sound, which showed a slightly enlarged right submandibular 
salivary gland with signs of chronic inflammation. Blood 
tests were normal and bone marrow examination did not 
show any signs of relapse. Chronic sialoadenitis was sus-
pected, and whenever the problem recurred, she was treated 
with oral antibiotics and steroids with full, but temporary, 
recovery. After 4 months and three acute relapsing episodes, 
she underwent again echotomography showing a growing 
salivary mass with some calcifications inside. A CT scan 
without contrast was prescribed confirming the presence of a 
mass contiguous to the salivary gland of 2.5 × 3 cm2.
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Objective: To report a rare case of a myeloid sarcoma of submandibular salivary gland.
Methods: A 65-year-old woman with a history of successfully treated myelodysplastic syndrome, presenting with periodic 
painful swelling of her right submandibular area.
Results: Physical evaluation, ultrasound and CT scan revealed the presence of a 3-cm mass contiguous to the submandibular 
salivary gland. A core needle biopsy confirmed the diagnosis of myeloid sarcoma. Bone marrow biopsy was still showing complete 
remission and the submandibular gland was the only extramedullary site involved. The patient was submitted to chemotherapy.
Conclusion: Myeloid sarcoma is a rare extramedullary neoplasm. It can virtually involve any anatomic site, but it usually 
involves lymph nodes, paranasal sinuses, skin, soft tissue and periostium. Myeloid sarcomas of salivary glands are very rare 
and ENTs should be aware of this disease in order to include it in the differential diagnosis of a solitary neck mass.
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Physical evaluation revealed a firm, non-tender, mobile, 
3-cm mass, palpable through the floor of the mouth. ENT 
examination was otherwise normal.
Blood tests were normal and fine-needle aspiration biopsy 
(FNAB) was performed. Since the findings, immediately 
evaluated by the pathologist, were not diagnostic, a core nee-
dle biopsy (CNB) was performed. Histopathologic examina-
tion demonstrated a diffuse and dense infiltrate of 
hemato-lymphoid cells within the salivary gland parenchyma. 
These atypical cells were medium sized and had mildly baso-
philic cytoplasm and round nuclei, with fine chromatin and 
inconspicuous nucleoli. Immunohistochemical examination 
was diagnostic for immature myeloid-monocytes expressing 
myeloperoxidase, CD68 (clone PGM-1) and CD34. The con-
clusion was MS with French–American–British M4.
Bone marrow biopsy was still showing complete remis-
sion and the submandibular gland was the only extramedul-
lary site involved, as a total-body CT scan showed. The 
patient was submitted to chemotherapy.
Discussion
MS is a rare neoplasm, which can very infrequently affect 
salivary glands. In the literature, there are very few reported 
cases of MS involving salivary glands and just a part of those 
involved the submandibular gland.
The rarity of MS makes this kind of diagnosis challenging 
and it can be missed or delayed if the possibility of MS is not 
included in the differential diagnosis. From this point of 
view, the role of ENT is crucial, being one of the first physi-
cians asked for a consultation in such cases. From a diagnos-
tic point of view, excision of the gland is often not needed, 
although FNAB is insufficient and CNB is usually required. 
Because of its rarity, MS can be misdiagnosed, the most 
common alternative diagnoses being lymphoma, undifferen-
tiated cancer, malignant melanoma, extramedullary hemat-
opoiesis and inflammation. For this reason, careful pathologic 
evaluation including immunohistochemistry is crucial for its 
accurate diagnosis.2,3
Therapy usually does not include surgery because MS has 
to be intended as a local manifestation of a systemic disease.
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